Zynerba Pharmaceuticals to Participate in Upcoming Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Zynerba Pharmaceuticals to Participate in Upcoming Investor Meetings and Conferences

DEVON, Pa., June 01, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate in various upcoming investor meetings and conferences, including:

  • The Jefferies 2016 Healthcare Conference on June 7, 2016 at 3:00 pm Eastern Daylight Time. The conference will take place at the Grand Hyatt in New York City.
  • The 3 rd Annual ROTH Healthcare Day on June 22, 2016 at The Dorchester in London, UK.

To listen to a webcast of the Jefferies presentation during the event, please visit the Investor Relations page of www.zynerba.com . A replay of this webcast will be available for 90 days following the conference.

About Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals (NASDAQ: ZYNE ) is a specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Zynerba is developing therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of two cannabinoids: cannabidiol (CBD), a non-psychoactive cannabinoid, and THC. Transdermal delivery has the potential to reduce adverse effects associated with oral dosing. ZYN002, the Company’s CBD gel, is the first and only synthetic CBD formulated as a patent protected permeation-enhanced gel and is being studied in refractory epilepsy, FXS and osteoarthritis. Zynerba is also developing ZYN001, which utilizes a synthetically manufactured pro-drug of THC in a transdermal patch to deliver THC through the skin and into the bloodstream. ZYN001 will be studied in fibromyalgia and peripheral neuropathic pain. Learn more at  www.zynerba.com  and follow the Company on Twitter at @ZynerbaPharma.

Cautionary Note on Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations. For example, there can be no guarantee that the Company will obtain approval for ZYN002 or ZYN001 from the U.S. Food and Drug Administration (FDA) or foreign regulatory authorities; even if ZYN002 or ZYN001 are approved, the Company may not be able to obtain the label claims that it is seeking from the FDA. Management’s expectations and, therefore, any forward-looking statements in this press release could also be affected by risks and uncertainties relating to a number of other factors, including the following: the success, cost and timing of the Company’s product development activities, studies and clinical trials; the success of competing products that are or become available; the Company’s ability to commercialize its product candidates; the size and growth potential of the markets for the Company’s product candidates, and the Company’s ability to service those markets; the Company’s ability to develop sales and marketing capabilities, whether alone or with potential future collaborators; the rate and degree of market acceptance of the Company’s product candidates; and the Company’s expectations regarding its ability to obtain and adequately maintain sufficient intellectual property protection for its product candidates. These and other risks are described in the Company’s periodic reports, including the annual report on Form 10K, quarterly reports on Form 10Q and current reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at  www.sec.gov . Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release. The Company assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

Investor Contacts Richard Baron, CFO Zynerba Pharmaceuticals 484.581.7505 baronr@zynerba.com Kimberly Minarovich Argot Partners 212.600.1902 kimberly@argotpartners.com Media Contact Eliza Schleifstein Argot Partners 973.361.1546 eliza@argotpartners.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 177

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 79

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 68

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
OCEG Faces China's Demographic Test After 40 Years

Updated Category News Views 61

A school group that once opened 35 kindergartens in a year is admitting the old playbook has run its course. That is the real message behind Oriental Cambridge Education Group's 40th-anniversary talk, not the balloons and ceremonial language. OCEG operates more than 170 institutions across 39 Chinese cities, and its chairman, Yu Yue, says the next chapter will be judged...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 150

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading
Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 72

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 57

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 121

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
A Hybrid Book Bets on Muscles, Myth, and Machines

Updated Category News Views 32

Few publishing pitches ask readers to carry a barbell into Tartarus, but A R Quigley is plainly not chasing the middle of the bookstore. Doctrina Machina Learning Machine, released by Palmetto Publishing in November 2026, welds together a strength-training guide and an underground military science-fiction war story. That is an odd little contraption, no use pretending...

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 130

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Private Aviation's Trust Crisis Amid Industry Consolidation

Updated Category News Views 182

The landscape of private aviation is transforming under a weighty cloak of financial strain and operational challenges. With recent disruptions in commercial flights grabbing headlines, travelers are sharpening their focus on safety rather than brand allure. As operators in this space grapple with tightening regulations and fluctuating customer expectations, the spotlight...

Continue Reading
CPSC Warns Against Hazards of EnHomee Tall Dressers

Updated Category News Views 329

Warning Issued on EnHomee Tall Dressers The U.S. Consumer Product Safety Commission (CPSC) has issued an urgent warning, advising consumers to stop using the EnHomee tall fabric dressers immediately. These dressers pose significant risks due to their instability if not securely anchored to the wall, potentially leading to serious injuries or even fatalities from tip-over...

Continue Reading
UK Retailers Adopt Automation Amid Rising Costs Challenges

Updated Category News Views 288

UK Retailers Turn to Automation for Savings Big retailers in the UK are ramping up their push for efficiency as they navigate rising operational costs. Key players such as Tesco (OTC: TSCDY), Sainsbury (LON: SBRY), Marks & Spencer, and Next (LON: NXT) are exploring automation and other cost-saving measures to maintain competitive pricing for their customers. Challenges...

Continue Reading
CenterPoint Energy Announces Increased Quarterly Dividend Payout

Updated Category News Views 154

CenterPoint Energy Announces New Dividend Rate CenterPoint Energy, Inc. has declared a regular quarterly cash dividend of $0.2200 per share for its common stock. This announcement was made by the Board of Directors and continues to showcase the company's commitment to shareholders. The dividend will be payable to stockholders of record on a specified date. This adjustment...

Continue Reading
Cincinnati Financial Reports Impressive Q3 Growth Figures

Updated Category News Views 73

Cincinnati Financial's Q3 Performance Overview Cincinnati Financial Corporation (NASDAQ: CINF) has recently unveiled its third-quarter results for the year, revealing a compelling narrative of growth despite some challenges in earnings. The insurer managed to outperform revenue expectations, posting impressive results that caught the eye of analysts and investors alike....

Continue Reading